Features

Breast Cancer Genes: When the Sequence Is Not Enough

Surgery, radiation, and chemotherapy are the mainstays of oncology, composing most of the first-line standard of care for virtually all cancers. As newer strategies are introduced into the therapeutic arsenal, particularly for earlier stages of disease, they are almost always tested in addition to, rather than instead of, the standard of care. Not only are these newer strategies proving effective in combination with the older methods, but surprisingly strong synergies are emerging among them. Several CCR investigators are finding ways to exploit these synergies for the benefit of patients. Read the full story »

Pediatric Tumors Made Personal

A mixed collection of relatively rare but often deadly pediatric tumors are collectively known as small round blue cell tumors (SRBCT) for precisely the reason one might imagine. Read more about pediatric tumors »

The Art of Silence

The transition from biology to technology is never as easy as it sounds, and taking technology out of the hands of artisans for widespread use adds another level of difficulty. Read more about the art of silencing genes »

News

Letting Sleeping Micrometastases Lie

An Accelerated Program
High school students help accelerate HIV structural biology research.

alt text High Marks for Destruction

Genetic variations boost HIV-killing immune response to slow disease progression.

alt text CliffsNotes for Your DNA

Changing the chromatin binding domain of lens epithelium-derived growth factor changes how HIV reads the host genome.

alt text Recent CCR Awards:

View the new 2009 CCR awards

alt text The Dual Effects of p53 on Differentiation

The p53 protein promotes differentiation and activates Wnt-mediated anti-differentiation.

alt text Everything in Its Right Place

Researchers identify genes that undergo spatial repositioning in breast cancer cells.

alt text In Conversation:

Research Fellow Karen Meaburn, Ph.D.

alt text Staff News at CCR

Staff announcements at CCR.

alt text Sending the Right Signals

Researchers identify mutations in B cell signaling.